Krsnaa Diagnostics Limited has successfully completed its postal ballot process on April 16, 2026, with shareholders overwhelmingly approving the re-appointment of Mr. Rajendra Khivraj Mutha as Executive Chairman for five consecutive years. The company has filed its official disclosure with BSE and NSE under Regulation 44, providing comprehensive voting results and scrutinizer's report.

Regulatory Compliance and Disclosure

The company submitted its formal disclosure to both stock exchanges on April 16, 2026, through reference number KDL/SE/003/2026-27. The postal ballot was conducted in strict compliance with Sections 108 and 110 of the Companies Act, 2013, along with Companies (Management and Administration) Rules, 2014, and various MCA circulars.

Comprehensive Voting Results

The postal ballot demonstrated exceptional shareholder participation with 59.9662% polling percentage and near-unanimous approval of 99.9951% for the resolution.

Category-wise Voting Performance

The resolution received unanimous support from promoter and promoter group shareholders, while public shareholders also demonstrated strong approval across institutional and non-institutional categories.

Promoter and Promoter Group

Public Institutional Shareholders

Public Non-Institutional Shareholders

Scrutinizer's Report and Validation

Mr. Dinesh Shivnarayan Birla (Membership No.: FCS-7658, COP: 13029), Practicing Company Secretary and Proprietor of Dinesh Birla & Associates, served as the appointed scrutinizer. The scrutinizer confirmed that 171 members voted in favour representing 19,451,298 votes (99.9951%), while 15 members voted against with 952 votes (0.0049%).

The complete voting results and scrutinizer's report have been made available on the company's website at www.krsnaadiagnostics.com , ensuring transparency and accessibility for all stakeholders. The successful completion enables continuity in the company's executive leadership structure with Mr. Rajendra Khivraj Mutha continuing as Executive Chairman for the next five years.

Krsnaa diagnostics Limited has completed its quarterly regulatory filing by submitting the confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31, 2026. The submission was made to both major stock exchanges on April 04, 2026, demonstrating the company's commitment to regulatory compliance.

Regulatory Compliance Details

The certificate was issued by KFin Technologies Limited, which serves as the registrar and share transfer agent for Krsnaa Diagnostics Limited. KFin Technologies Limited holds SEBI Registration Number INR000000221, authorizing it to perform these regulatory functions. The certificate confirms that all required details regarding securities dematerialized and rematerialized during the specified quarter have been properly furnished to stock exchanges.

Stock Exchange Notifications

The compliance certificate was simultaneously submitted to both major Indian stock exchanges where Krsnaa Diagnostics shares are traded. The company maintains its listing presence across these platforms, ensuring comprehensive regulatory coverage.

Certificate Authentication

The submission was authenticated by Sujay Sudipta Bose, Company Secretary and Compliance Officer of Krsnaa Diagnostics Limited. The document bears digital signatures dated April 04, 2026, ensuring proper authorization and compliance with electronic filing requirements. KFin Technologies Limited's Vice President Dnyanesh Gharote signed the certificates on behalf of the registrar.

Regulatory Framework

Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 mandates that registrars and share transfer agents provide quarterly confirmations regarding dematerialization and rematerialization activities. This requirement ensures transparency in securities handling and maintains investor confidence in the depository system. The regulation applies to all listed companies and their appointed registrars, forming a crucial part of India's securities market infrastructure.

The timely submission of this certificate reflects Krsnaa Diagnostics Limited's adherence to regulatory timelines and its commitment to maintaining good corporate governance practices. Such compliance activities are essential for listed companies to maintain their standing with regulatory authorities and stock exchanges.